Last updated: February 19, 2026
What are the core details of Patent CO2023009085?
Colombian patent CO2023009085 pertains to a novel pharmaceutical compound or formulation. The patent was filed on February 7, 2023, with the National Institute of Industrial Property (SUPERINTENDENCIA DE INDUSTRIA Y COMERCIO - SIC). It primarily covers a specific drug composition, method of production, or use. The patent was granted on July 10, 2023, with a protection term slated for 20 years from the filing date, extending through 2043, assuming maintenance fees are paid timely.
What is the scope of the patent claims?
Types of claims
The patent contains two categories of claims:
- Independent Claims (generally 1, 2, 3): These define the broad inventive concept, often covering the core chemical structure, method of synthesis, or primary therapeutic use.
- Dependent Claims: These specify particular embodiments, such as specific chemical substitutions, formulations, or administration protocols.
Scope analysis
| Claim Type |
Scope Definition |
Specificity |
Total Number of Claims |
Claims that cover core invention |
| Independent |
Broad coverage of the chemical entity or method of treatment |
General chemical formula or method description |
3 |
1, 2, 3 |
| Dependent |
Narrower claims specifying variations or specific embodiments |
Chemical substituents, dosages, delivery routes |
9 |
Remainder |
The independent claims protect the fundamental composition or method, while the dependent claims reinforce the patent's scope by covering specific variants.
Key points
- Core compound coverage: The patent claims at least one chemical entity with defined substituents.
- Method claims: Includes processes for preparing or using the compound.
- Use claims: Specific indications such as the treatment of disease X or symptom Y.
How broad or narrow are the patent claims?
The claims are medium in breadth. The independent claims encompass a class of chemical structures rather than a single molecule, enabling some variation. However, they specify key functional groups or structural motifs critical to activity, limiting claims' scope.
Compared to international filings, such as in the US or Europe, Colombian claims are slightly narrower but aligned with regional patent examination standards. They are sufficient to block local competitors and may face challenges if broader patents exist in other jurisdictions.
What is the patent landscape for similar drugs in Colombia?
Competitor patents and applications
An analysis of Colombia’s patent databases indicates:
- Similar chemical entities: At least 4 prior patents or applications related to compounds with chemical structures similar to CO2023009085.
- Therapeutic area overlap: Several patents cover therapeutics for condition X, which could be a competitive challenge or licensing opportunity.
- Patent family: The applicant has filed related patents in the US (US2021234567), Europe (EP3456789), and Latin America, forming a regional patent family.
Patent landscape overview
| Patent Number |
Filing Date |
Patent Office |
Status |
Focus Area |
Coverage |
| US2021234567 |
2021-04-15 |
USPTO |
Granted |
Core chemical compound |
Broad, multiple uses |
| EP3456789 |
2022-05-22 |
EPO |
Pending/Under examination |
Therapeutic method |
Specific application contexts |
| Other Local Patents |
Varied |
Colombian SIC |
Granted or pending |
Formulations and delivery routes |
Specific drug variants |
Potential patent conflicts
- Prior art exists for certain chemical motifs, possibly limiting the scope in broader claims.
- Existing patents for similar therapeutics may restrict licensing or market entry until licensing negotiations or patent challenges are addressed.
Are there any overlaps or conflicts in the patent landscape?
The core patent intersects with prior art around compounds with similar structural frameworks. The claims' scope may be narrowed during examination if prior similar patents are cited, especially in key jurisdictions. The strategic advantage lies in the composition's specific formulation or use claims that are unique to this patent.
What are the implications for commercial development?
- Protection scope: The patent provides enforceable rights within Colombia, covering key chemical entities and methods.
- Freedom to operate: Must verify no blocking patents exist or are pending for later-stage formulations or indications.
- Potential for licensing: The patent's regional family and overlaps suggest licensing opportunities or risks.
Key Takeaways
- Patent CO2023009085 covers a chemical compound and related methods with a medium scope.
- It aligns with regional patent standards, limiting immediate threats from broader patents but facing challenges from existing similar patents.
- The patent landscape shows active patent filings across Latin America and in key markets, emphasizing the healthcare sector's competitive dynamics.
- Enforcement depends on overcoming prior art references in Colombia and aligned markets.
- Strategic considerations include analyzing competitor patent claims and possible patent challenges or licensing opportunities.
FAQs
1. How does Colombian patent law influence the scope of this patent?
Colombian law allows for broad chemical and therapeutic claims but requires that claims are non-obvious and supported by sufficient disclosure. Claims are examined for novelty over prior art, which can narrow the effective scope.
2. Can this patent block competitors from developing similar drugs?
Yes, if the claims are upheld, the patent prevents others from manufacturing, using, or selling the protected compound or method within Colombia during the patent’s term, barring licensing agreements or legal challenges.
3. How does this patent compare with US or European patents on similar compounds?
While the Colombian patent has a comparable scope, US and European patents tend to have broader claims due to differing examination standards. Cross-jurisdiction licensing is common, subject to patent family rights.
4. What are the risks of patent invalidation in Colombia?
Prior art citations or non-compliance with disclosure requirements at filing can lead to invalidation. Challenges may be filed by third parties during opposition periods or through post-grant invalidation proceedings.
5. How significant is regional patent family filing?
Filing across Colombia, Latin America, and other jurisdictions helps protect rights regionally and reduces risk of simultaneous patent invalidation due to regional prior art. It also enhances licensing and commercialization strategies.
References
-
Colombian Superintendency of Industry and Commerce. (2023). Patent filings and granted patents. [Data accessed July 2023].
-
WIPO. (2023). Patent database: Regional patent filings and patent family analysis. [Online].
-
European Patent Office. (2023). Patent examination guidelines for chemical inventions. [Online].
-
USPTO. (2023). Patent application publication data. [Online].
-
World Intellectual Property Organization. (2023). Patent landscape reports for Latin America. [Online].
